The ongoing antidepressant and anti-anxiety benefits of brexanolone, a drug approved for the treatment of postpartum depression, for weeks after treatment may lie in how it alters oscillations in regions of the brain associated with mood
For years, Tufts researchers have been on the cutting edge of investigating and treating the mysterious illness known as Lyme disease. Now, a new initiative seeks to eradicate the disease once and for all.